GSK Launches A 1 Million Dollar Healthcare Innovation Award
The giant pharmaceutical company, GSK, and Save the Children have launched a 1 million dollar award for this year’s developing country healthcare innovations that aim to reduce child deaths.
The award is part of an ambitious partnership between GSK and Save the Children which aims to help save the lives of a million of the world’s poorest children A statement sent to DireTube from Save the Children has indicated that this year’s Healthcare Innovation Award seeks entries that demonstrate new approaches to increasing people’s access to health services in developing countries.
This year’s event will mark the third annual $1 million Healthcare Innovation Award that rewards innovations in healthcare that have helped to reduce child deaths in developing countries. “From the 15 July – 7 September 2015, organizations from across developing countries can nominate examples of innovative health approaches they have implemented. These approaches must have resulted in tangible improvements to under-5 child survival rates, be sustainable and have the potential to be scaled-up and replicated,” Save the Children said.
Ramil Burden, vice-president for Africa and Developing Countries at GSK, said: “Robust healthcare systems are the backbone of thriving communities but too many countries still lack the trained health workers and facilities they need to manage everyday health challenges, let alone crises like the catastrophic outbreak of Ebola.”
Co-chaired by Sir Andrew Witty, CEO of GSK, and Justin Forsyth, CEO of Save the Children, a judging panel, made up of experts from the fields of public health, science and academia, will award all or part of the funds to one or more of the best healthcare innovations.